{"id":2183,"date":"2013-02-08T16:38:33","date_gmt":"2013-02-08T07:38:33","guid":{"rendered":"http:\/\/vps36.rbrc.jp:8193\/?page_id=2183"},"modified":"2020-12-18T11:24:26","modified_gmt":"2020-12-18T02:24:26","slug":"hps_diseaselist","status":"publish","type":"page","link":"http:\/\/cell.brc.riken.jp\/en\/hps\/hps_diseaselist","title":{"rendered":"List of diseases"},"content":{"rendered":"

*When you want to use some Disease-specific iPS cells, please e-mail to the following address.
\n*In relation to the information that are not described below, please e-mail to the following address.<\/p>\n

Contact us :\u00a0cellips.brc\"\"riken.jp<\/a><\/p>\n

Blue letter cells are available. You obtain the information by clicking the blue letter.
\n*iPS cells created using the Sendai virus vector are now available<\/a><\/p>\n

Update : 2016.10.11
\n<\/a><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Name of diseases<\/th>\nPatient No<\/th>\nHPS<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\nReference<\/th>\n<\/tr>\n
1. Spinal-Bulbar Muscular Atrophy (SBMA) \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Spinal-Bulbar Muscular Atrophy (SBMA)<\/td>\n1<\/td>\nHPS0350<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0479<\/td>\nHPS0480<\/td>\nHPS0481<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
<\/a>3<\/td>\nHPS0482<\/td>\nHPS0483<\/td>\nHPS0484<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
2. Amyotrophic lateral sclerosis (ALS) \u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Amyotrophic lateral sclerosis (ALS)<\/td>\n1<\/td>\nHPS0059<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0247<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0248<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\nHPS0249<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\nHPS0250<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6<\/td>\nHPS0251<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7<\/td>\nHPS0252<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8<\/td>\nHPS0253<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
9<\/td>\nHPS0327<\/a><\/td>\nHPS0290<\/a><\/td>\nHPS0291<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 22855461<\/a><\/td>\n<\/tr>\n
10<\/td>\nHPS0292<\/a><\/td>\nHPS0293<\/a><\/td>\nHPS0294<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 22855461<\/a><\/td>\n<\/tr>\n
11<\/td>\nHPS0419<\/td>\nHPS0420<\/td>\nHPS0421<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
12<\/td>\nHPS0473<\/td>\nHPS0474<\/td>\nHPS0475<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
13<\/td>\nHPS0476<\/td>\nHPS0477<\/td>\nHPS0478<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
14<\/td>\nHPS0485<\/td>\nHPS0486<\/td>\nHPS0487<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
Amyotrophic lateral sclerosis (ALS), familia amyotrophic lateral sclerosis (FALS)<\/td>\n1<\/td>\nHPS0140*<\/a><\/td>\nHPS0141*<\/td>\nHPS0142*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Amyotrophic lateral sclerosis (ALS), bulbar, with UMN (bulbar, with UMN)<\/td>\n1<\/td>\nHPS0146*<\/a><\/td>\nHPS0147*<\/a><\/td>\nHPS0148*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Amyotrophic lateral sclerosis (ALS), classical, with UMN (classical, with UMN)<\/td>\n1<\/td>\nHPS0128*<\/td>\nHPS0129*<\/a><\/td>\nHPS0130*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Amyotrophic lateral sclerosis (ALS), pseudo-polyneuritic, w\/o UMN
\n (pseudo-polyneuritic, w\/o UMN)<\/td>\n		<\/a>1<\/td>\nHPS0134*<\/a><\/td>\nHPS0135*<\/td>\nHPS0136*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3. Spinal muscular atrophy \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Spinal muscular atrophy, SMA Type I<\/td>\n1<\/td>\nHPS0235*<\/td>\nHPS0236*<\/td>\nHPS0237*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0158<\/td>\nHPS0159<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Spinal muscular atrophy, SMA type III (Kugelberg-Welander disease)<\/td>\n1<\/td>\nHPS0229*<\/td>\nHPS0230*<\/td>\nHPS0231*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0115<\/td>\nHPS0116<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4. Primary lateral sclerosis (PLS) \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Primary lateral sclerosis (PLS)<\/td>\n1<\/td>\nHPS0414<\/a> \"NEW\"\u00a0<\/td>\nHPS0415<\/td>\nHPS0416<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0417<\/td>\nHPS0418<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5. Parkinson’s disease (PD)<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Parkinson’s disease (PD)<\/td>\n1<\/td>\nHPS0264<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0435<\/td>\nHPS0436<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0491<\/td>\nHPS0492<\/td>\nHPS0493<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a> <\/td>\n<\/tr>\n
4<\/td>\nHPS0509<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\nHPS0510<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Parkinson’s disease (PD), Familial type, PARK2<\/td>\n1<\/td>\nHPS0096<\/td>\nHPS0097<\/a><\/td>\nHPS0098<\/td>\nHPS0099<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0304<\/td>\nHPS0305<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6. Huntington’s disease <\/span>\u00a0<\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Huntington’s disease<\/td>\n<\/a>1<\/td>\nHPS0263<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7. Charcot-Marie-Tooth disease\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Charcot-Marie-Tooth disease<\/td>\n1<\/td>\nHPS0426<\/a> \"NEW\"\u00a0<\/td>\n<\/td>\nHPS0427<\/td>\nHPS0428<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0429<\/a> \"NEW\"\u00a0<\/td>\nHPS0430<\/td>\nHPS0431<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0432<\/td>\nHPS0433<\/td>\nHPS0434<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\nHPS0507<\/a> \"NEW\"\u00a0<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>5<\/td>\nHPS0508<\/a> \"NEW\"\u00a0<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8. Congenital myasthenic syndromes \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Congenital myasthenic syndromes <\/td>\n1<\/td>\nHPS0982<\/td>\nHPS0983<\/td>\nHPS0984<\/td>\nHPS0985<\/td>\nHPS0986<\/td>\nHPS0987<\/td>\nHPS0988<\/td>\nHPS0989<\/td>\nHPS0990<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS1066<\/td>\nHPS1067<\/td>\nHPS1068 <\/td>\nHPS1069<\/td>\nHPS1070 <\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
9. Inclusion body myositis \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Inclusion body myositis<\/td>\n<\/a>1<\/td>\nHPS0181*<\/td>\nHPS0182*<\/td>\nHPS0183*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0351<\/a><\/td>\n<\/td>\nHPS0352<\/a><\/td>\n<\/td>\nHPS0353<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
10. Spinocerebellar Degeneration \u00a0\u00a0<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Spinocerebellar Degeneration<\/td>\n1<\/td>\nHPS0422<\/td>\nHPS0423<\/td>\nHPS0424<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0425<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0464<\/td>\nHPS0465<\/td>\nHPS0466<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
4<\/td>\nHPS0467<\/td>\nHPS0468<\/td>\nHPS0469<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
5<\/td>\nHPS1074<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
11. Lysosomal storage disease \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Metachromatic leukodystrophy (MLD)<\/td>\n1<\/td>\nHPS0238*<\/td>\nHPS0239*<\/td>\nHPS0240*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Tay-Sachs’ disease (RCB0697 GM2-1TKB)<\/td>\n1<\/td>\nHPS0149*<\/a><\/td>\nHPS0150*<\/a><\/td>\nHPS0151*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Niemann-Pick disease, variant biochemical phenotype C<\/td>\n<\/a>1<\/td>\nHPS0488<\/td>\nHPS0489<\/td>\nHPS0490<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
12. Mitochondrial encephalomyopathy \u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Mitochondrial encephalomyopathy<\/td>\n1<\/td>\nHPS0069*<\/td>\nHPS0070*<\/a><\/td>\nHPS0071*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0458<\/td>\nHPS0459<\/td>\nHPS0460<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
<\/a>3<\/td>\nHPS0461<\/td>\nHPS0462<\/td>\nHPS0463<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
13. Moyamoya disease \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Moyamoya disease<\/td>\n<\/a>1<\/td>\nHPS0215*<\/a><\/td>\nHPS0216*<\/td>\nHPS0217*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0241*<\/td>\nHPS0242*<\/td>\nHPS0243*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
14. Amyloid neuropathy\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Amyloid neuropathy, Familial type<\/td>\n1<\/td>\nHPS0224*<\/a><\/td>\nHPS0225*<\/td>\nHPS0226*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0227*<\/a><\/td>\nHPS0228*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
15. Dermatomyositis (DM)\u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Dermatomyositis (DM)<\/td>\n<\/a>1<\/td>\nHPS0172*<\/td>\nHPS0173*<\/td>\nHPS0174*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
16. Progressive systemic sclerosis (PSS) \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Progressive systemic sclerosis (PSS)<\/td>\n1<\/td>\nHPS0178*<\/a><\/td>\nHPS0179*<\/td>\nHPS0180*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0184*<\/a><\/td>\nHPS0185*<\/a><\/td>\nHPS0186*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
17. Sj\u00f6gren’s syndrome \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Sj\u00f6gren’s syndrome<\/td>\n<\/a>1<\/td>\nHPS0437<\/td>\nHPS0438<\/td>\nHPS0439<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
18. Primary Immunodeficiency Database \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Adenosine deaminase deficiency (ADA)<\/td>\n1<\/td>\nHPS0265<\/a><\/td>\nHPS0266<\/a><\/td>\nHPS0267<\/td>\nHPS0268<\/td>\nHPS0269<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Chronic granulomatous disease (CGD), p47phox-deficiency<\/td>\n1<\/td>\nHPS0334*<\/a><\/td>\nHPS0335*<\/a><\/td>\nHPS0336*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
X-linked Chronic granulomatous disease (X-CGD), gp91phox-deficiency)<\/td>\n<\/a>1<\/td>\nHPS0337*<\/a><\/td>\nHPS0338*<\/a><\/td>\nHPS0339*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>19. Hypopituitarism \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Hypopituitarism <\/td>\n<\/a>1<\/td>\nHPS1073<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
20. Pulmonary hypertension \u00a0<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Pulmonary hypertension<\/td>\n<\/a>1<\/td>\nHPS0209*<\/a><\/td>\nHPS0210*<\/td>\nHPS0211* <\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
21. Retinitis pigmentosa \u00a0<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Retinitis pigmentosa<\/td>\n1<\/td>\nHPS0061<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0062<\/a><\/td>\nHPS0104<\/td>\nHPS0105<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0072<\/a><\/td>\nHPS0106<\/td>\nHPS0107<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\nHPS0073<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\nHPS0074<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6<\/td>\nHPS0075<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7<\/td>\nHPS0938<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>8<\/td>\nHPS1075<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
22. Cryopirin-associated periodic syndrome (CAPS) <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Chronic infantile neurological cutaneous and articular syndrome (CINCA syndrome)\n<\/td>\n1<\/td>\nHPS0117<\/a><\/td>\nHPS0118<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 22723549<\/a><\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0119<\/a><\/td>\nHPS0120<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 22723549<\/a><\/td>\n<\/tr>\n
23. Congenital myopathy \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Congenital fiber type disproportion disease<\/td>\n<\/a>1<\/td>\nHPS0143*<\/a><\/td>\nHPS0144*<\/td>\nHPS0145*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
24. Muscular dystrophy \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular dystrophy, Duchenne type<\/td>\n1<\/td>\nHPS0163*<\/td>\nHPS0164*<\/a><\/td>\nHPS0165*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0166*<\/td>\nHPS0167*<\/td>\nHPS0168*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0169*<\/a><\/td>\nHPS0170*<\/td>\nHPS0171*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\nHPS0312 <\/td>\nHPS0313<\/td>\nHPS0314<\/td>\nHPS0315<\/td>\nHPS0316<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\nHPS0383<\/td>\nHPS0384<\/td>\nHPS0385<\/td>\nHPS0386<\/td>\nHPS0387<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 25434822<\/a><\/td>\n<\/tr>\n
Muscular dystrophy, Duchenne type (manifesting carrier)<\/td>\n1<\/td>\nHPS0317<\/a><\/td>\nHPS0318<\/td>\nHPS0319<\/td>\nHPS0320<\/td>\nHPS0321<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS0322*<\/a><\/td>\nHPS0323*<\/td>\nHPS0324*<\/td>\nHPS0325*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular dystrophy, Becker type<\/td>\n1<\/td>\nHPS0232*<\/td>\nHPS0233*<\/a><\/td>\nHPS0234*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular dystrophy, Limb-girdle type<\/td>\n1<\/td>\nHPS0198*<\/td>\nHPS0199*<\/td>\nHPS0200*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular dystrophy, Miyoshi type <\/td>\n1<\/td>\nHPS0131*<\/td>\nHPS0132*<\/td>\nHPS0133*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular dystrophy, Myotonic Dystrophy<\/td>\n1<\/td>\nHPS0393<\/td>\nHPS0394<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0395<\/td>\nHPS0396 <\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0540<\/td>\nHPS0541<\/td>\nHPS0542<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
25. Periodic paralysis\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Periodic paralysis<\/td>\n<\/a>1<\/td>\nHPS1062<\/td>\nHPS1063<\/td>\nHPS1064<\/td>\nHPS1065<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
26. Frontotemporal dementia\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Frontotemporal dementia<\/td>\n<\/a>1<\/td>\nHPS0470<\/td>\nHPS0471<\/td>\nHPS0472<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
27. Congenital hypomyelinating luekodystrophy \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Allan-Herndon syndrome<\/td>\n1<\/td>\nHPS0152*<\/td>\nHPS0153*<\/td>\nHPS0154*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Pelizaeus-Merzbacher disease<\/td>\n<\/a>1<\/td>\nHPS0066*<\/td>\nHPS0067*<\/td>\nHPS0068*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>28. Xeroderma pigmentosum\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Xeroderma pigmentosum (A)<\/td>\n1<\/td>\nHPS1750 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Xeroderma pigmentosum (C)<\/td>\n1<\/td>\nHPS1000<\/td>\nHPS1001<\/td>\nHPS1002<\/td>\nHPS1003<\/td>\nHPS1004<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS1751 \"NEW\"<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
29. Ehlers-Danlos syndrome \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Ehlers-Danlos syndrome, Kosho Type<\/td>\n1<\/td>\nHPS0212*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0213*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0214*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
30. Wilson’s disease \u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Wilson’s disease\u00a0\u00a0
\nRCB0390 NCU-F3
\nRCB0391 NCU-F4
\nRCB0395 NCU-F8\n<\/td>\n		1<\/td>\nHPS0049<\/a><\/td>\nHPS0050<\/td>\nHPS0051<\/td>\nHPS0052<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0053<\/a><\/td>\nHPS0054<\/td>\nHPS0055<\/td>\nHPS0056<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>3<\/td>\nHPS0045<\/a><\/td>\nHPS0046<\/td>\nHPS0047<\/td>\nHPS0048<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
31. Hypophosphatasia \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Hypophosphatasia, perinatal type<\/td>\n<\/a>1<\/td>\nHPS0332<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0333<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
32. X-Linked \u03b1-Thalassemia, Mental Retardation Syndrome (ATR-X syndrome)<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
X-Linked \u03b1-Thalassemia, Mental Retardation Syndrome (ATR-X syndrome)<\/td>\n<\/a>1<\/td>\nHPS0207*<\/a><\/td>\nHPS0208*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS1007*<\/td>\nHPS1008*<\/td>\nHPS1009*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
33. Werner syndrome\u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Werner syndrome
\n(RCB0407 WS2TKB)<\/td>\n		<\/a>1<\/td>\nHPS0193<\/td>\nHPS0284<\/td>\nHPS0285<\/td>\nHPS0286<\/td>\nHPS0287<\/td>\nHPS0288<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
34. Cockayne’s syndrome \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Cockayne’s syndrome
\n(RCB0397 NCU-F10)<\/td>\n		<\/a>1<\/td>\nHPS0083*<\/a><\/td>\nHPS0084*<\/td>\nHPS0085*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
35. Prader-Willi Syndrome \u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Prader-Willi Syndrome
\n(RCB1560 PWS-Yamaguchi)<\/td>\n		<\/a>1<\/td>\nHPS0080*<\/td>\nHPS0081*<\/td>\nHPS0082*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
36. Glycogen storage disease, type II (Pompe\u2019s disease) \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Glycogen storage disease, type II (Pompe’s disease)<\/td>\n<\/a>1<\/td>\nHPS0175*<\/a><\/td>\nHPS0176*<\/a><\/td>\nHPS0177*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
37. Glycogen storage disease, Type 1b \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Glycogen storage disease, Type 1b<\/td>\n<\/a>1<\/td>\nHPS0064*<\/a><\/td>\nHPS0065*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
38. Nakajo-Nishimura Syndrome \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Nakajo-Nishimura Syndrome<\/td>\n<\/a><\/a>1<\/td>\nHPS0517<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0518<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
39. Fibrodysplasia ossificans progressiva (FOP)\u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Fibrodysplasia ossificans progressiva (FOP)<\/td>\n<\/a>1<\/td>\nHPS0376<\/a><\/td>\nHPS0377<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 24321451 <\/a><\/td>\n<\/tr>\n
2<\/td>\nHPS0378<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 24321451 <\/a><\/td>\n<\/tr>\n
40. Osteogenesis Imperfecta \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Osteogenesis Imperfecta<\/td>\n<\/a>1<\/td>\nHPS0525<\/td>\nHPS0526<\/td>\nHPS0527<\/td>\nHPS0528<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0942 \"NEW\"<\/td>\nHPS0943 \"NEW\"<\/td>\nHPS0944 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>3<\/td>\nHPS0945 \"NEW\"<\/td>\nHPS0946 \"NEW\"<\/td>\nHPS0947 \"NEW\"<\/td>\nHPS0948 \"NEW\"<\/td>\nHPS0949 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>4<\/td>\nHPS0950 \"NEW\"<\/td>\nHPS0951 \"NEW\"<\/td>\nHPS0952 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
41.Achondroplasia\u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Achondroplasia <\/td>\n1<\/td>\nHPS0388<\/td>\nHPS0389<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0522<\/a><\/td>\nHPS0523<\/td>\nHPS0524<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>3<\/td>\nHPS0529<\/td>\nHPS0530<\/td>\nHPS0531<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>4<\/td>\nHHPS0939 \"NEW\"<\/td>\nHHPS0940 \"NEW\"<\/td>\nHPS0941 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>5<\/td>\nHPS0953 \"NEW\"<\/td>\nHPS0954 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
42. Fanconi anemia\u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Fanconi anemia<\/td>\n<\/a>1<\/td>\nHPS0511<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0512<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>43. Epstein syndrome<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Epstein syndrome<\/td>\n1<\/td>\nHPS0452<\/td>\nHPS0453<\/td>\nHPS0454<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a><\/td>\n<\/tr>\n
44. Macular dystrophy \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Age related Macular degeneration<\/td>\n1<\/td>\nHPS1072<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Best disease<\/td>\n<\/a>1<\/td>\nHPS1012 <\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
45. Leber Hereditary Optic Neuropathy \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Leber Hereditary Optic Neuropathy<\/td>\n<\/a>1<\/td>\nHPS1071<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
46. Bardet-Biedl syndrome \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Bardet-Biedl syndrome<\/td>\n<\/a>1<\/td>\nHPS0155*<\/td>\nHPS0156*<\/a><\/td>\nHPS0157*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
47. Gelatinous drop-like corneal dystrophy <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Gelatinous drop-like corneal dystrophy<\/td>\n<\/a>1<\/td>\nHPS1013<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
48. Muscular channelopathy<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular channelopathy<\/td>\n1<\/td>\nHPS0967<\/td>\nHPS0968<\/td>\nHPS0969<\/td>\nHPS0970<\/td>\nHPS0971<\/td>\nHPS0972<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0979<\/td>\nHPS0980<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0981<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\nHPS0991<\/td>\nHPS0992<\/td>\nHPS0993<\/td>\nHPS0994\/td>\nHPS0995<\/td>\nHPS0996<\/td>\nHPS0997<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>5<\/td>\nHPS1057<\/td>\nHPS1058<\/td>\nHPS1059<\/td>\nHPS1060\/td>\nHPS1061<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
49. Severe congenital neutropenia \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Severe congenital neutropenia<\/td>\n<\/a>1<\/td>\nHPS0218<\/td>\nHPS0219<\/td>\nHPS0220<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
50. Juvenile nephronophthisis \u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Juvenile nephronophthisis<\/td>\n1<\/td>\nHPS0446<\/td>\nHPS0447<\/td>\nHPS0448<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a><\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0449<\/td>\nHPS0450<\/td>\nHPS0451<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a><\/td>\n<\/tr>\n
51. Ornithine transcarbamylase deficiency (OTCD) \u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Ornithine transcarbamylase deficiency (OTCD)
\n(RCB0492 OTCD1TKB)<\/td>\n		<\/a>1<\/td>\nHPS0086*<\/td>\nHPS0087*<\/a><\/td>\nHPS0088*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
52. Pseudo congenital lactic acidosis\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Pseudo congenital lactic acidosis
\n\uff08RCB0266 CLA1RGB\uff09<\/td>\n		<\/a>1<\/td>\nHPS0201*<\/td>\nHPS0202*<\/td>\nHPS0203*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
53. Alzheimer disease \u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Alzheimer disease<\/td>\n1<\/td>\nHPS0254<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0255<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0256<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\nHPS0257<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\nHPS0258<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6<\/td>\nHPS0259<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7<\/td>\nHPS0260<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8<\/td>\nHPS0261<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\uff19<\/td>\nHPS0262<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 21900357<\/a><\/td>\n<\/tr>\n
10<\/td>\nHPS1745<\/td>\nHPS1747<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23434393<\/a><\/td>\n<\/tr>\n
11<\/td>\nHPS1746><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23434393<\/a><\/td>\n<\/tr>\n
Alzheimer disease , Familial type<\/td>\n1<\/td>\nHPS0362<\/td>\nHPS0363<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 21900357<\/a><\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0364<\/td>\nHPS0365<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 21900357<\/a><\/td>\n<\/tr>\n
54. Dementia of Alzheimer’s type\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Dementia of Alzheimer’s type<\/td>\n<\/a>1<\/td>\nHPS0060<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
55. Familial central diabetes insipidus \u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Familial central diabetes insipidus<\/td>\n<\/a>1<\/td>\nHPS0407<\/td>\nHPS1010<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS1011<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
56. Reticular\u00a0dysgenesis<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Reticular\u00a0dysgenesis<\/td>\n<\/a>1<\/td>\nHPS0513<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0514<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
57. Rheumatoid Arthritis \u00a0<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Rheumatoid Arthritis<\/td>\n1<\/td>\nHPS0440<\/td>\nHPS0441<\/td>\nHPS0442<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0443<\/td>\nHPS0444<\/td>\nHPS0445<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
58. Miyoshi myopathy\u00a0<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Miyoshi myopathy<\/td>\n1<\/td>\nHPS0390<\/td>\nHPS0391<\/td>\nHPS0392<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0397<\/td>\nHPS0398<\/td>\nHPS0399<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0408<\/td>\nHPS0409<\/td>\nHPS0410<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\nHPS0961<\/td>\nHPS0962<\/td>\nHPS0963<\/td>\nHPS0964<\/td>\nHPS0965<\/td>\nHPS0966<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>5<\/td>\nHPS0973<\/td>\nHPS0974<\/td>\nHPS0975<\/td>\nHPS0976<\/td>\nHPS0977<\/td>\nHPS0978<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
59. Long QT Syndrome and Brugada Syndrome\u00a0\u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Long QT Syndrome and Brugada Syndrome, P631fs\/33<\/td>\n<\/a>1<\/td>\nHPS0221<\/td>\nHPS0222<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
60. Ch\u00e9diak-Higashi syndrome\u00a0<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Ch\u00e9diak-Higashi syndrome<\/td>\n<\/a>1<\/td>\nHPS0515<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0516<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>61. Kostmann syndrome \u00a0<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Kostmann syndrome<\/td>\n1<\/td>\nHPS0519<\/td>\nHPS0520<\/td>\nHPS0521<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
62. Bernard-Soulier syndorome \u00a0<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Bernard-Soulier syndorome<\/td>\n1<\/a><\/td>\nHPS0078<\/a><\/td>\nHPS0079<\/td>\nHPS0190<\/td>\nHPS0191<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
63. Pyruvate dehydrogenase deficiency \u00a0<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Pyruvate dehydrogenase deficiency
\n\uff08RCB0546 AT-PDH1TKB\uff09<\/td>\n		<\/a>1<\/td>\nHPS0204*<\/td>\nHPS0205*<\/td>\nHPS0206*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
64. Atopic dermatitis \u00a0<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Atopic dermatitis<\/td>\n<\/a>1<\/td>\nHPS0270<\/a><\/td>\nHPS0271<\/a><\/td>\nHPS0272<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
65. Allergic rhinitis\u00a0<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Allergic rhinitis (Pollen allergy)<\/td>\n<\/a>1<\/td>\nHPS0192<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
66. iPS-like cells derived from colorectal adenocarcinoma<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
iPS-like cells derived from colorectal adenocarcinoma<\/td>\n1<\/td>\nHPS0112<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

*When you want to use some Disease-specific iPS cells, please e-mail to the following address. *In relation to the information that are not described below, please e-mail to the following address. Contact us :\u00a0cellips.brcriken.jp Blue letter cells are available. You obtain the information by clicking the blue letter. *iPS cells created using the Sendai virus vector are now available Update : 2016.10.11 Name of diseases Patient No HPS Reference 1. Spinal-Bulbar Muscular Atrophy (SBMA) \u00a0\u00a0 Spinal-Bulbar Muscular Atrophy (SBMA) 1 HPS0350 2 HPS0479 HPS0480 HPS0481 PMID: 23193063 24399248 3 HPS0482 HPS0483 HPS0484 PMID: 23193063 24399248 2. Amyotrophic lateral sclerosis (ALS) \u00a0 Amyotrophic lateral sclerosis (ALS) 1 HPS0059 2 HPS0247 3 HPS0248 4 HPS0249 5 HPS0250 6 HPS0251 7 HPS0252 8 HPS0253 9 HPS0327 HPS0290 HPS0291 PMID: 22855461 10 HPS0292 HPS0293 HPS0294 PMID: 22855461 11 HPS0419 HPS0420 HPS0421 12 HPS0473 HPS0474 HPS0475 PMID: 23193063 24399248 13 HPS0476 HPS0477 HPS0478 PMID: 23193063 24399248 14 HPS0485 HPS0486 HPS0487 PMID: 23193063 24399248 Amyotrophic lateral sclerosis (ALS), familia amyotrophic lateral sclerosis (FALS) 1 HPS0140* HPS0141* HPS0142* Amyotrophic lateral sclerosis (ALS), bulbar, with UMN (bulbar, with UMN) 1 HPS0146* HPS0147* HPS0148* Amyotrophic lateral sclerosis (ALS), classical, with UMN (classical, with UMN) 1 HPS0128* HPS0129* HPS0130* Amyotrophic […]<\/p>\n","protected":false},"author":13,"featured_media":0,"parent":148,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_analysis_target_kw":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-2183","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/2183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=2183"}],"version-history":[{"count":20,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/2183\/revisions"}],"predecessor-version":[{"id":10218,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/2183\/revisions\/10218"}],"up":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/148"}],"wp:attachment":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=2183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}